Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection
Authors
Keywords
-
Journal
Science Advances
Volume 5, Issue 7, Pages eaaw4197
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-07-25
DOI
10.1126/sciadv.aaw4197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Tumor Cells: Diagnostic and Therapeutic Applications
- (2018) Eric Lin et al. Annual Review of Biomedical Engineering
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
- (2018) Jordan A. Krall et al. Science Translational Medicine
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
- (2018) Raedeh Saraei et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery
- (2017) Bindu Thapa et al. INTERNATIONAL JOURNAL OF CANCER
- PARP inhibitor combination therapy
- (2016) Amy Dréan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer
- (2016) Elizabeth C. Wayne et al. JOURNAL OF CONTROLLED RELEASE
- Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?
- (2016) Noriyoshi Sawabata et al. SURGERY TODAY
- The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
- (2015) Xiaoxia Zhu et al. Frontiers in Endocrinology
- Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis via Disruption of Fas Signaling-initiated Cancer-related Inflammation
- (2014) Qiuyan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry
- (2014) Abenaa M Brewster et al. LANCET ONCOLOGY
- TRAIL-coated leukocytes that kill cancer cells in the circulation
- (2014) M. J. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors
- (2013) Michael J Mitchell et al. NEW JOURNAL OF PHYSICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- TRAIL on trial: preclinical advances in cancer therapy
- (2013) Daniel W. Stuckey et al. TRENDS IN MOLECULAR MEDICINE
- Computational and Experimental Models of Cancer Cell Response to Fluid Shear Stress
- (2013) Michael J. Mitchell et al. Frontiers in Oncology
- E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells
- (2012) Michael J. Mitchell et al. JOURNAL OF CONTROLLED RELEASE
- Inducing Apoptosis in Rolling Cancer Cells: A Combined Therapy with Aspirin and Immobilized TRAIL and E-Selectin
- (2012) Kuldeepsinh Rana et al. MOLECULAR PHARMACEUTICS
- Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells
- (2011) David J Taylor et al. BMC CANCER
- In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell - endothelial cell interaction
- (2010) Peter Gassmann et al. BMC CANCER
- Imagable 4T1 model for the study of late stage breast cancer
- (2008) Kai Tao et al. BMC CANCER
- Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
- (2008) Maura N. Dickler et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative hemostatic parameters in BALB/c, C57BL/6 and C3H/He mice
- (2008) Mariana Barrios et al. THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More